Cargando…
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% preva...
Autores principales: | Petersen, Maria Skaalum, Strøm, Marin, Christiansen, Debes Hammershaimb, Fjallsbak, Jógvan Páll, Eliasen, Eina Hansen, Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Gaini, Shahin, Møller, Lars Fodgaard, Steig, Bjarni, Weihe, Pál |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588539/ https://www.ncbi.nlm.nih.gov/pubmed/32726200 http://dx.doi.org/10.3201/eid2611.202736 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
por: Petersen, Maria Skaalum, et al.
Publicado: (2021) -
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
por: Petersen, Maria Skaalum, et al.
Publicado: (2022) -
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2021) -
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2022) -
Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.
por: Strøm, Marin, et al.
Publicado: (2020)